McKesson Corp (MCK)

Industry Medical Distribution
This stock can be held in an Investment ISA and an Investment Account
Sell

$670.01

Buy

$689.00

arrow-up$0.26 (+0.04%)

McKesson Corp provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. It operates with two segments namely McKesson Distribution Solutions and McKesson Technology Solutions.
Prices updated at 14 May 2025, 00:25 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.72%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Distribution
Chairman
Mr. Donald R. Knauss
CEO
Dr. Brian S. Tyler,PhD
Most recent earnings
31 Mar 2025
Fiscal year end
31 Mar 2025
Employees
51,000
Head office
6555 State Highway 161
Irving
United States
75039
mobile
+1 972 446-4800
letter
investors@mckesson.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Dr. Brian S. Tyler,PhD
Director and Chief Executive Officer
1.49m--19.00m-
Mr. Dominic J. Caruso
Independent Director
0.14m--0.34m-
Dr. Deborah L. Dunsire,M.D.
Independent Director
-----
Mr. Donald R. Knauss
Chairman of the Board
0.24m--0.56m-
Mr. W. Roy Dunbar
Independent Director
0.12m--0.32m-
Mr. Kevin M. Ozan
Independent Director
0.03m--0.14m-
Dr. Richard H. Carmona, M.D.
Independent Director
0.12m--0.32m-
Mr. Bradley E. Lerman
Independent Director
0.14m--0.34m-
Ms. Maria N. Martinez
Independent Director
0.14m--0.34m-
Mr. Britt J. Vitalone
Executive Vice President and Chief Financial Officer
0.94m--6.78m-
Ms. Michele Lau
Executive Vice President and Chief Legal Officer
0.18m1.50m-8.81m-
Mr. Napoleon B. Rutledge, Jr
Senior Vice President, Controller and Principal Accounting Officer
-----
Mr. Thomas L. Rodgers
Executive Vice President, Chief Strategy and Business Development Officer
0.61m--3.18m-
Mr. James H. Hinton
Independent Director
0.12m--0.32m-
Ms. Kathleen Wilson-Thompson
Independent Director
0.12m--0.32m-
Ms. LeAnn B. Smith
Executive Vice President and Chief Human Resources Officer
0.64m0.10m-3.54m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc11,886,8560.118-162595-1.34939830 Apr 20259.51
BlackRock Inc10,439,9990.12039-685005-6.15734630 Apr 20258.35
State Street Corp5,710,8230.12856-170273-2.8952630 Apr 20254.57
MFS Investment Management KK4,603,5331.02994-116147-2.46090830 Apr 20253.68
Massachusetts Financial Services Company4,603,5331.02994-116147-2.46090830 Apr 20253.68

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
09 Dec 2024-Ms. LeAnn B. Smith602.81349,0271,443--
05 Sep 2024-Dr. Brian S. Tyler,PhD561.102,105,80878,586--
05 Aug 2024-Dr. Brian S. Tyler,PhD626.032,349,49182,339--
31 Jul 2024-Mr. Dominic J. Caruso--349--
31 Jul 2024-Dr. Deborah L. Dunsire,M.D.--349--
31 Jul 2024-Mr. Donald R. Knauss--349--
31 Jul 2024-Mr. Donald R. Knauss--195--
31 Jul 2024-Mr. W. Roy Dunbar--349--
31 Jul 2024-Mr. Kevin M. Ozan--349--
31 Jul 2024-Dr. Richard H. Carmona, M.D.--349--
31 Jul 2024-Mr. Bradley E. Lerman--349--
31 Jul 2024-Ms. Maria N. Martinez--349--
31 Jul 2024-Mr. James H. Hinton--349--
03 Jul 2024-Dr. Brian S. Tyler,PhD580.922,180,19386,092--
11 Jun 2024-Ms. LeAnn B. Smith585.53351,3182,022--
07 Jun 2024-Ms. Maria N. Martinez585.88282,979---
05 Jun 2024-Dr. Brian S. Tyler,PhD574.412,155,76189,845--
03 Jun 2024-Dr. Deborah L. Dunsire,M.D.--56--
31 May 2024-Mr. Thomas L. Rodgers560.992,935,1002,544--
30 May 2024-Dr. Brian S. Tyler,PhD--93,598--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.